Clinical Trials Directory

Trials / Terminated

TerminatedNCT01183442

Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia

Effects of Vitamin D Supplementation in Coronary Artery Disease Patients With Postchallenge Hyperglycemia and Vitamin D Deficiency on Endothelial Function and Insulin Sensitivity

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The main aim of the investigation is to clarify, whether vitamin D supplementation in coronary artery disease patients with vitamin D deficiency and postchallenge hyperglycemia has an impact on endothelial dysfunction and parameters of insulin sensitivity and beta-cell function.

Detailed description

An improvement of endothelial dysfunction as a cardiovascular surrogate parameter could be translated in a reduced risk for future cardiovascular events, which is of major interest, since patients with postchallenge hyperglycemia face a significantly higher cardiovascular risk than patients with normal glucose tolerance. Furthermore an improvement in insulin sensitivity and/or beta-cell function would identify vitamin D as an important strategy for the prevention of type 2 diabetes. In consideration of the rapidly increasing prevalence of diabetes and the failure of current prevention strategies this could be an important, safe and cheap way to support ongoing lifestyle modifying programs. Our study of course investigates surrogate cardiovascular and insulin sensitivity parameters. Assuming a beneficial effect of vitamin D in our study, this concept would have to be proven in further large outcome as well as diabetes prevention trials.

Conditions

Interventions

TypeNameDescription
DRUGvitamin Dorally administered 2800 IU of vitamin D or placebo daily

Timeline

Start date
2010-06-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2010-08-17
Last updated
2015-04-17

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01183442. Inclusion in this directory is not an endorsement.